Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline-Reference-Cited by-同舟云学术

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Published:2015-11 Issue:6 Volume:11 Page:514-516
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Van Poznak Catherine¹,Harris Lyndsay N.¹,Somerfield Mark R.¹

Affiliation:

1. Seidman Cancer Center, Case Western Reserve University, Cleveland, OH; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and American Society of Clinical Oncology, Alexandria, VA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2015.005215

Reference2 articles.

1. C Van Poznak, MR Somerfield, RC Bast , etal: The use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology clinical practice guideline J Clin Oncol doi: 10.1200/JCO.2015.61.1459

2. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer;Cancer Cell International;2024-03-19

2. Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer;Breast Cancer Research and Treatment;2024-01-06

3. Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan;Breast Cancer;2023-12-09

4. Prevalent Landscape of Tumor Genomic Alterations of Luminal B1 Breast Cancers Using a Comprehensive Genomic Profiling Assay in Taiwan;2023-08-17

5. Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor;Journal of Pathology and Translational Medicine;2023-07-15